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Abstract
The present report summarises a workshop convened by the UK Food Standards Agency (Agency) on 25 March 2010 to discuss the current
Agency’s funded research on the use of metabolomics technologies in human nutrition research. The objectives of this workshop were to
review progress to date, to identify technical challenges and ways of overcoming them, and to discuss future research priorities and the
application of metabolomics in public health nutrition research and surveys. Results from studies nearing completion showed that by using
carefully designed dietary and sampling regimens, it is possible to identify novel biomarkers of food intake that could not have been
predicted from current knowledge of food composition. These findings provide proof-of-principle that the metabolomics approach can
be used to develop new putative biomarkers of dietary intake. The next steps will be to validate these putative biomarkers, to develop
rapid and inexpensive assays for biomarkers of food intake of high public health relevance, and to test their utility in population
cohort studies and dietary surveys.
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On 25 March 2010, the UK Food Standards Agency
(Agency) convened a workshop, chaired by Dr Augustin
Scalbert, to review the Agency’s funded nutrition research
projects using metabolomics technologies. This workshop
aimed to establish priorities and directions for future
research in the field.
Diet is a key modifiable factor affecting the long-term
health andwell-beingof individuals. Todetermine the effects
of specific dietary components and/or patterns on health,
detailed knowledge of habitual dietary exposure is required.
Currently, nutritional studies investigating associations
between diet and health rely on study participants either
reporting or recalling their dietary intake over a period of
time using FFQ or diet diaries. However, these approaches
have limitations because individuals rarely keep accurate
and complete records of what they eat, and the task of keep-
ing records can influence the foods that individuals eat
during the recording period(1,2). One potential solution is
to examine body fluids such as plasma and urine for bio-
markers specific to particular foods or diets using metabolo-
mics approaches. However, the lack of robust, validated
biomarkers of different foods is currently a barrier.
Following consumption, many of the chemical
components in foods are absorbed either directly or after
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digestion, undergo transformations in the gastrointestinal
tract and/or liver and appear in the plasma. Later, these
compounds may appear, with or without further transfor-
mation and metabolism, in the urine. These metabolites
derived from food form what has been called the food
metabolome(3,4). Investigation of the food metabolome in
biofluids has the potential to give objective information
about the short-term or long-term dietary intake of indivi-
duals, to identify potential biomarkers and to reduce the
current reliance on subjective dietary records.
Dr Scalbert presented two ways of identifying potential
biomarkers: a targeted ‘top-down’ approach involving
analysis of the composition of foods and selection of candi-
date molecules that are likely to appear in the plasma or
urine(5,6) and an untargeted ‘bottom-up’ approach. In the
untargeted approach, volunteers consume different diets
or foods, and metabolomics technologies are used to
identify potential biomarkers from the food metabolome.
The advantage of this approach(7–9) is that it makes no
assumptions about candidate molecules. Experience has
shown that where biomarkers have been identified using
the untargeted approach, the candidate molecules
identified often are unexpected based on current incom-
plete knowledge of the composition of the foods
consumed, their absorption and subsequent metabolism.
However, where an untargeted approach is used in
biomarker identification studies, particularly those using
urine, care is required in selecting the experimental
procedures. Other issues raised included the specificity of
biomarkers for particular foodstuffs, the variability of
composition of individual foods and inter-individual
variation in the absorption and metabolism of different
food components.
In closing the introduction to the workshop, Dr Scalbert
made two key points. First, that proper biocuration of food
composition and metabolomics data will be essential, and
second, it is highly desirable that research moves to testing
metabolomics technologies in population cohort studies
and dietary surveys.
Identification of biomarkers of dietary intake using
metabolomics
Professor John Mathers presented the protocols used in the
MEtabolomics to characterise Dietary Exposure (MEDE)
study. This study focused on providing ‘proof-of-principle’
that an untargeted (‘bottom-up’) metabolomics approach
could identify specific chemical signals typical of individual
meal components. To minimise the effects of potential
confounding factors, carefully prepared standard operating
procedures (SOP) were developed in parallel with the
GrainMark study (see later). These SOP covered key
aspects of volunteer handling, volunteer behaviours
(including water consumption), test-meal preparation and
timing, biofluid (blood, urine and saliva) collection, pro-
cessing and storage to reduce potential confounding
effects. The SOP developed in the MEDE study were
applied to the other Agency-funded projects.
Three studies were undertaken. In MEDE 1, twelve
volunteers were studied, each on one occasion to assess
the robustness of the protocols. In MEDE 2, a further
twelve volunteers underwent two identical test procedures,
receiving a standard evening meal (a ready-prepared roast
chicken dinner with a chocolate eclair and still mineral
water) and a standard breakfast (orange juice, croissant,
tea and cornflakes with milk) several weeks apart to inves-
tigate the intra-individual variation between the two
cohorts. In MEDE 3, twenty-four volunteers were allocated
to receive the standard evening meal and breakfast twice
or variations of the standard breakfast (known as ‘test
breakfast’) in which one component (cornflakes with
milk) was replaced with one of four food components of
high public health interest (a cruciferous vegetable (broc-
coli), an oily fish (smoked salmon), berry fruit (raspberries)
or a whole-grain cereal food (wheat biscuits)) in a four
6 £ 6 Latin square design. This part of the study tested
whether metabolomics analysis could distinguish between
the metabolome from the standard breakfast and the test
breakfasts. In addition, data from MEDE 3 were used to
identify novel putative biomarkers of intake of each of
the test foods.
Professor John Draper presented the detailed results
obtained from analysis of the MEDE study samples.
It was observed that metabolome models of plasma/
serum are dominated by individual differences in blood
composition, whereas for postprandial urine samples
(which are relatively easy to collect non-invasively), the
metabolome content is dominated by recent dietary
exposure. Two techniques were used for metabolite finger-
printing (flow infusion electrospray mass spectrometry
(FIE-MS) and gas chromatography-time-of-flight-mass
spectrometry (GC-TOF-MS)), and both were informative.
GC-TOF-MS resulted in more robust models for discri-
mination of samples collected after the different test
breakfasts. However, FIE-MS allowed the analysis of
many more samples in a much shorter period of time.
Key findings from the initial analysis of the MEDE study
samples were as follows:
(1) Consistent fasting and postprandial changes were
detected in the urine in all subjects following con-
sumption of the standard breakfast and when test
meals were consumed several weeks apart.
(2) Urine and plasma samples collected 3 h after test meals
were the most informative about recent dietary
exposure.
(3) The same metabolite signals were always highly
ranked when the same standard breakfast was
consumed. This meant that they could be ‘filtered’
from the data and made it much easier to identify
metabolite signals associated with the test foods.

















(4) Inter-individual differences were also observed,
possibly because of differences in genotype for
genes encoding enzymes and other proteins involved
in the transport, metabolism and excretion of food
constituents.
(5) Several behavioural, anthropomorphic and physio-
logical factors appeared to have a minimal effect on
biomarker discovery.
The conclusion from this part of the study was that the
analytical procedures and data analysis tools used are
robust and suitable for biomarker discovery. The data gener-
ated have been mined for biomarkers of particular dietary
ingredients. Potential putative biomarkers were identified
for consumption of orange juice, raspberries, smoked
salmon and broccoli. This demonstrated the considerable
potential of metabolomics as a route to identify and develop
novel and robust biomarkers of dietary exposure.
Three findings from the data analysis were particularly
striking. First, biomarkers that might have the potential to
be general indicators of total fruit and vegetable con-
sumption were identified, and it is worth noting that many
of these represented metabolites biotransformed in the
body which would not have been discovered if analysis
had been limited to any pre-determined chemical found in
the foods concerned. Second, for the twenty-four volunteers
as a whole, it was not possible to distinguish the presence of
cornflakes from wheat biscuits (a whole-grain cereal) in the
standard breakfast. However, when a subset of volunteers
with similar metabolite profiles was examined, good
separation of the two breakfast cereals was achieved.
Although it is possible that the analytical approaches used
may not have been sufficiently sensitive to distinguish
between the two breakfast cereals, an alternative expla-
nation could be that inter-individual differences in the
metabolism of food (metabotypes – which may be geneti-
cally controlled) obscured differences in metabolite finger-
prints between the breakfast cereals. Finally, it was
observed that provision of adequate water intake following
the evening meal minimised variation in the concentration
of solutes in the following morning’s fasting urine samples.
Professor Chris Seal and Dr Manfred Beckmann
presented data on the identification and utility of biomarkers
for monitoring whole grain intake (the GrainMark study).
This study involved both a traditional targeted approach
‘top-down’ and an untargeted ‘bottom-up’ approach utilising
metabolomics. In the targeted approach, an assessment was
made of the utility of alkylresorcinols and mammalian
lignans (enterodiol and enterolactone) as biomarkers of
whole grain intake. Alkylresorcinols are phenolic lipids,
which are found exclusively in the bran fractions of cereals
(except oats and rice of the commonly consumed cereals).
Enterodiol and enterolactone are metabolites of the plant
lignans formed in the large intestine by the gut microbiota.
Plant lignans are found in a variety of plant foods including
fruits, vegetables, seeds and whole-grain cereals. In the
untargeted approach, the objective was to identify plasma
and urinary metabolome profiles indicative of diets rich in
whole-grain wheat and whole-grain rye.
The GrainMark study involved sixty-eight healthy, non-
smoking, normal-weight adult volunteers. After a 4-week
washout period in which volunteers avoided all whole-
grain foods, they consumed three servings of either
whole-grain wheat or whole-grain rye per day for 4
weeks. Volunteers then doubled their dose of whole-
grain foods for the next 4 weeks. Blood and urine samples
were collected at the beginning and end of each
intervention period, and the protocols developed in
parallel with the MEDE study were used for the standard
evening meal and urine sample collection. Samples were
analysed for alkylresorcinols (GC–MS) and lignan
metabolites (HPLC), and metabolite fingerprints were
generated by FIE-MS and GC-TOF-MS.
The targeted approach was successful as the plasma
concentrations of alkylresorcinols were strongly and
significantly correlated with whole grain intake for both
wheat and rye groups. In addition, the ratio of C17:C21
lipid chain-length alkylresorcinols was a good indicator
of the type of whole grain consumed. The plasma concen-
trations of lignan metabolites were less informative, but
urinary excretion of these metabolites could be used as a
biomarker of whole grain intake.
When the untargeted approach was used to analyse
GrainMark samples, a correlation between the metabolome
profile and whole grain intake was found using both the
GC-TOF-MS and FIE-MS methods. However, quality assess-
ment of the data showed that only GC-TOF-MS had real
utility. This result was not too surprising given that FIE-
MS involves sample classification by rapid, global analysis
of metabolites without an initial chromatography step.
In addition, the metabolites that are potential biomarkers
of bran consumption are easier to detect by GC-TOF-MS,
which also is a global profiling tool. The aim of the Grain-
Mark study was to look for potentially subtle differences in
metabolite profile associated with long-term dietary
changes. As such, samples from this study are akin to
those which might be available from population cohort
studies and dietary surveys.
Analysis of spot urine samples proved to be more
informative than plasma analysis, as this yielded a greater
number of metabolites that discriminated strongly the differ-
ent intervention phases. This is an important finding because
it reduces the likelihood that 24 h urine collection will be
required. Two of the promising metabolites identified were
3,5-dihydroxybenzoic acid and 3-(3,5-dihydroxyphenyl)-
1-propanoic acid, both of which are metabolites of alkylre-
sorcinols. A number of other metabolites whose identity is
currently unknown were found to be indicative of whole-
grain rye intake. This provides evidence that use of the
untargeted approach in nutrition biomarker studies can
generate additional, and potentially more informative,
biomarkers to those identified by the targeted approach.

















Professor John Beattie described a project that is
underway in collaboration with the University of Abery-
stwyth and the University of Colorado: the Human
Biomarkers of Zinc Status study. Some groups of the UK
population have a low Zn intake, and this may have
important public health implications. Unfortunately, there
are no sensitive, specific and reliable biomarkers of Zn
dietary exposure and status. The study is being conducted
in 100 healthy male volunteers who will be supplied with
all their food during the 10-week study period. Throughout
the trial, twenty of the volunteers will be on a high-Zn diet.
The remaining eighty volunteers will be maintained on a
low-Zn diet throughout the trial but will be randomly
allocated to four groups of twenty individuals who will
receive supplements of 0, 3, 6 or 9 mg of Zn/d, for the
final 4 weeks. Blood and urine samples will be analysed
using metabolite fingerprinting and profiling to search for
potential biomarkers of Zn status.
Metabolomics analysis will identify metabolic pathways
that are influenced by Zn status, which will be quantified
by measuring the exchangeable Zn pool size using a
stable isotope tracer technique. Blood plasma proteomics
will also be used to search for potential protein biomarkers
of Zn status and to investigate associations between
protein and metabolite profiles. Thus, the Human
Biomarkers of Zinc Status study not only focuses on
products of endogenous metabolism, but also considers
Zn-related influences on the metabolism of food-derived
compounds. This study is due to report at the end of 2012.
Dr John Lodge described a project that is underway in
collaboration with the University of Aberystwyth to identify
dose-responsive biomarkers of sucrose intake in healthy
female volunteers. Carbohydrate represents the major
energy source in the UK diet, but there are no accurate bio-
markers of carbohydrate intake. Highly refined or extrinsic
sugar intake can lead to consumption of excess energy,
which could increase the risk of weight gain and so accurate
measures of intake are of major nutritional importance. As in
the MEDE study, volunteers are given a standard evening
meal and urine is collected overnight. The next day,
volunteers are randomised (thirty volunteers per group) to
consume a drink containing either 0, 50 or 100 g of sucrose
in 500 ml of water while in the fasted state. This is followed
by a standard lunch and evening meal. Blood and urine
samples are taken immediately before sucrose ingestion
and at intervals for the next 24 hours, and these biofluids
will be analysed by metabolite fingerprinting. This project
is due to report in the second half of 2011.
In each of the studies described earlier, the participants
were required to conform to a controlled dietary regimen.
However, a key objective in the application of metabolo-
mics technology to nutrition studies is to develop new
biomarkers that can be used in free-living populations to
estimate intakes of specific foods or dietary patterns.
Such biomarkers may be used to validate, or as an
alternative to, conventional measures of dietary intake in
large-scale surveys or to explore diet–health associations
in observational studies, particularly in large multi-centre
or international settings. There is information in the
literature(10) showing that metabolic profiles can be used
to distinguish between subjects from different population
groups and between those with high vegetable protein
intake v. high animal protein intake.
Dr Mazda Jenab and Dr Hector Keun described the
potential application of biological samples collected in
observational studies for metabolomics and biomarker
discovery. Specifically, they highlighted the suitability of a
cross-sectional component of the European Prospective
Investigation into Cancer and Nutrition (EPIC) study
to assist in translating metabolomics studies to whole
populations. The EPIC cross-sectional study is a subset of
the larger EPIC cohort study(11,12), and is composed of
subjects (stratified by sex, age range and smoking status)
recruited from sixteen European countries from Scandinavia
to southern Greece and including the UK with different
dietary and lifestyle patterns. Baseline dietary intake infor-
mation for these subjects is available from both detailed
country-specific FFQ and standardised and computerised
24 h dietary recalls collected using the EPIC-Soft program.
Information on lifestyle (including smoking, alcohol
consumption and physical activity) was collected at
recruitment using standardised questionnaires. Anthropo-
metric measures as well as biological samples (stored
under liquid nitrogen) were also collected at baseline and
are available for all subjects. In addition, a large number of
traditional dietary biomarkers (carotenoids, tocopherols,
retinol and phospholipid fatty acids) have already been
measured in the dataset(13–15). To explore the suitability of
EPIC biological samples for metabolomics analyses, a pilot
study was conducted in a small subset of samples. Metabolic
profiles of blinded serum samples from a total of forty
subjects from the British, French and Italian cohorts were
analysed by NMR and MS. In addition, ten blinded samples
were analysed in duplicate along with several quality-control
samples. The results of this pilot study showed that:
(1) most samples could be differentiated by the country
of origin;
(2) similar discrimination could be obtained with either
NMR or MS;
(3) blinded duplicate samples could be identified,
indicating methodological robustness.
These results are encouraging and suggest that a
metabolomic fingerprinting approach may be applicable
to population studies using biological samples not pre-
viously collected specifically with metabolomics analyses
in mind.
Conclusions and key issues
From the workshop, it is clear that suitable methodology
for volunteer handling and for sample collection,

















preparation and analysis is available to permit use of an
untargeted metabolomics approach to identify new
biomarkers of dietary exposure. However, three caveats
must be considered. First, adequate quality-control
methods need to be developed to ensure that the analytical
procedures used are suitable for the analysis of large
batches or to compare different batches of samples.
Second, careful thought needs to be given to the quality
of all consumables and SOP used in sample collection,
preparation, storage and analysis to facilitate comparison
of the results obtained in various independent studies.
Third, existing mass spectral databases lack information
on many of the food-derived metabolites identified in
metabolic fingerprints. Thus, such databases need further
development to facilitate rapid identification of potential
biomarkers of food intake.
Metabolomics methods generate large amounts of data
and the Agency’s previously funded research developed
methods for automated analysis of such data(16–18).
These methods permit an assessment of the quality of
data models and those mass spectral signatures that
explain differences between sample classes. These
methods were used in the MEDE and GrainMark studies,
and their utility has been confirmed. Nevertheless, much
more attention should be paid to the biocuration of
metabolomics data, with the aims of archiving both
existing knowledge on the food metabolome (nature of
compounds, concentration in foods and spectral data) in
a form that can be easily queried, and the new data
generated in new metabolomics studies.
Although both plasma and urine can be analysed for the
presence of food-derived biomarkers, with the present
state of development of nutritional metabolomics, urine
appears to be the preferred biofluid because:
(1) a greater diversity of metabolites derived from the
food metabolome is observed in the urine;
(2) collecting urine samples is relatively easy and non-
invasive;
(3) spot urine samples collected at particular times in
relation to meals and sleep period (‘behavioural
phase’ urines) can be informative, and collection of
24 h urine samples may not be required.
However, the possibility of using plasma to identify
biomarkers of food intake should not be ignored. For
example, the lipophilic fraction of the plasma (food) meta-
bolome may contain several biomarkers of long-term food
consumption such as alkylresorcinols or carotenoids.
Looking to the future, increases in the sensitivity of
metabolite measurements in the plasma may enable
characterisation of long-term (habitual) dietary exposure
by detecting and quantifying metabolites which have
been sequestered in body tissues and which appear in
the blood through normal tissue turnover.
In the past, the Agency has funded a number of
nutritional intervention trials that have not included
metabolomics analysis. Samples from these trials have
been stored, and they could now be re-examined to
determine if relevant biomarkers can be identified.
A potential confounding issue is the long-term stability of
each metabolite originally present in the samples. How-
ever, such possible instability should not be a barrier to
analysis provided it is acknowledged as an issue and the
storage history of samples is known.
As a number of participants in the workshop high-
lighted, there is now a need to move from the discovery
of potential biomarkers of food intake in carefully
controlled study groups to their validation and appli-
cation in dietary surveys and prospective cohort
studies where there are also data on health outcomes.
The EPIC study has provided proof-of-principle that the
metabolomics methodology can be translated to these
types of studies. However, untargeted metabolomics
approaches, particularly those using MS, are not yet suf-
ficiently robust to analyse very large numbers of samples.
Such untargeted metabolomics approaches could be
applied to a limited number of selected samples in
cross-sectional, case–control or nested studies within
large cohort studies(19), which have robust data on food
intake obtained using conventional dietary assessment
tools to help in the validation of novel putative bio-
markers of food intake. Other validation approaches
may include additional testing in controlled dietary inter-
vention studies. Following validation, the next steps
would be the development of targeted analytical methods
for low-cost, high-throughput quantification of the new
biomarkers and their application in larger cohort studies
and dietary surveys.
Lastly, individuals differ in the way in which they
handle food metabolites because of differences in the
activity of transmembrane transporters and/or enzymes
that transform metabolites in the liver and other tissues.
These different ‘metabotypes’ may reflect different geno-
types, although differences in gut microbiota also could
contribute to inter-individual differences for some metab-
olites. Such differences in metabotype, particularly
if prevalent in the population, may prevent validation
of some newly discovered markers for food intake and
confound attempts to link dietary intake (based on
metabolite biomarkers) to health outcomes. Conversely,
once identified, stratification of subjects on the basis of
their metabotypes may explain differences in the strength
of associations between intake of a particular nutrient or
food and health/disease outcomes. Much useful infor-
mation on the genetic and biochemical basis of metabo-
types is available from pharmacological and toxicological
research because similar biochemical pathways are
involved in the transport, metabolism and excretion of
xenobiotics, and of non-nutrient food components.
Research is needed to develop rapid methods for deter-
mining individual metabotypes that can be applied in a
nutritional context.

















Recommendations for future research
A number of research recommendations were suggested
that would advance progress towards the overall goal
of using metabolomics to assess dietary intake. These
recommendations included the following:
(1) Determine whether particular biomarkers (individual
compounds or groups of compounds) can be used
as quantitative or qualitative indicators of consum-
ption of particular classes of nutrients (micro and
macro) or foods (e.g. fruits and vegetables) or of
adoption of particular dietary patterns (e.g. Mediterra-
nean diet).
(2) Develop a database of food-derived metabolites (food
metabolome) to facilitate the rapid identification of
biomarkers from unannotated metabolite signals in
urine or plasma fingerprints.
(3) Build a toolbox of experimental and informatics
methods to facilitate biomarker discovery and validation.
(4) Once suitable biomarkers have been identified,
develop targeted methods of analysis using more
conventional analytical procedures (e.g. enzyme-
linked immunoassays) to allow their high-throughput
quantification.
(5) Develop and validate robust metabolomics methodo-
logies that can be applied to larger numbers of urine
and plasma samples to explore the direct application
of metabolomics to population cohort studies and
dietary surveys.
(6) Determine the influence of metabolic phenotype
(differences in metabotype) on the relationships
between dietary exposure and metabolite concen-
trations/patterns in the blood and urine. This
recommendation will advance understanding of the
mechanisms responsible for inter-individual variability
in food-related biomarkers. Outcomes from such
research could also provide key information, which
could be used to strengthen conclusions of causality
in studies of associations between dietary intake and
health/disease outcomes.
(7) Develop metabolomics approaches to identify unde-
clared confounding behaviour (e.g. intake of alcohol
and prescription drugs) in studies of links between
diet and health.
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